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RECENTLY Dewhurst and Kitchen
(1972) described the synthesis and puri-
fication of a series of 6-substituted
benzo(a)pyrenederivatives. Evidence was
obtained that carboxaldehyde prepared
by the route described by Fieser and
Hershberg (1938) might have been con-
taminated by benzo(a)pyrene. Particular
care was taken to purify the present
derivatives from unreacted parent hydro-
carbon.
These 6-substituted derivatives have
been tested for carcinogenicity in mice
after subcutaneous injection and the
findings compared with published data
on the carcinogenicity of the structurally
similar 7-substituted benz(a)anthracene
derivatives. Additionally, the formation
of charge transfer complexes with iodine
and acridine has been examined in an
attempt to clarify the question ofwhether
both donor and acceptor properties com-
bined in the same molecule (Allison and
Nash, 1963) or either property alone
(Huggins and Yang, 1962) is necessary
for carcinogenesis.
MATERIALS AND METHODS
Young female Balb/c mice were used in
groups of 20 to test for carcinogenic activity.
Throughout the experiment they were kept
in groups of 10 on a standard laboratory
pellet diet with water ad libitum. The
compounds for test were dissolved in propy-
lene glycol and injected at the rate of 1 mg
of hydrocarbon in 0-2 ml per animal. In the
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case of 6-hydroxymethyl benzo(a)pyrene
only 0 5 mg per animal was given (as a fine
suspension) because of its low solubility and
previously determined high toxicity. For
each experimental group, a control group
injected with propylene glycol only was
set up.
All animals were examined weekly for
tumours and when one appeared the animal
was killed and the tumour removed and fixed
in Bouin's fixative. Sections were made
and stained with haematoxylin and eosin.
After 2 years the experiment was terminated
and all animals still apparently tumour free
were killed and autopsied.
The methods of Szent-Gyorgyi, Isenberg
and Baird (1960) for iodine complex forma-
tion and of Szent-Gyorgyi and McLaughlin
(1961) for acridine complex formation were
used.
RESULTS
The experimental findings are given
in Table I. No tumours appeared in the
control groups and none was found in
the animals autopsied at the end of the
experiment. The tumours found in the
experimental groups all arose at or around
the site of injection and in all cases were
found to be fibrosarcomata. A number
of animals died of natural causes during
the course of the experiment, but since
all these deaths occurred before any
tumours appeared they have been ex-
cluded from the calculations. The relative
potencies of the derivatives tested have
been assessed using the Iball index (Iball,
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TABLE I.-Results ofExperiments with 6-substituted Benzo(a)pyrene Derivatives
Compound
Propylene glycol
(control)
Benzo(a)pyrene
Benzo(a)pyrene
-6-carbox-
aldehyde
Benzo(a)pyrene
-6-carbonitrile
-6 Bromobenzo-
(a)pyrene
Benzo(a)pyrene-
6-carbonamide
6 Methylbenzo-
(a)pyrene
6 Hydroxy-
methylbenzo-
(a)pyrene
Tumour-
bearing/
tumour-free
animals
0/17
10/6
7/10
0/18
1/17
0/17
12/4
5/10
% incidence
of tumour-
significance
0
* 63
P < 0-001
41
0-02 > P > 0-01
0
5-5
0-98 > P > 0-95
0
75
P < 0-001
33
0-025 > P > 0-02 .
Mean latent
period (days)
and range
156
(105-305)
140
(112-210)
Iball
index
Iodine
complex
formation
Acridine
complex
formation
40 . Strong . Strong
29 . Nil Strong
- . Nil . Weak
509 1 . Nil . Nil
- . Nil . Weak
256
(140-560)
279
(252-357)
29 . Strong . Nil
11 . Weak . Nil
Significances were calculated using the chi squared test with Yates correction.
Complex formation with iodine indicates electron donor properties and with acridine electron acceptor
properties.
DISCUSSION
Shear and Leiter (1940) found the
6-methyl and the 6-carboxaldehyde deri-
vatives to be carcinogenic and Lacassagne,
Buu Ho! and Zajdela (1957) confirmed the
carcinogenicity of the 6-carboxaldehyde.
The carcinogenicity ofthe older samples of
carboxaldehyde could have been due to
benzo(a)pyrene present as a contaminant.
The maximum benzo(a)pyrene content of
the specimen of 6-carboxaldehyde used in
the present study was 1 part in 10,000 and
the Iball index for the aldehyde was 29
as against 40 for the parent hydrocarbon.
This implies that the 6-carboxaldehyde is
undoubtedly a carcinogen in its own right.
The previously observed carcinogenicity
of the 6-methyl derivative was confirmed.
The 6-hydroxymethyl compound was
found to be carcinogenic, the 6-bromo
compound was possibly aweak carcinogen,
whilst the 6-nitrile and 6-amidederivatives
appeared non-carcinogenic. These last
4 compounds had not been examined
before.
A comparison of the carcinogenicity
data with the complex formation data
shows that in the case of benzo(a)pyrene
itself the carcinogenic potential is associ-
ated with both donor and acceptor
properties in the same molecule. The
strong acceptor benzo(a)pyrene-6-carbox-
aldehyde proved to have the same Iball
index as the strong donor 6-methyl benzo-
(a)pyrene. The weak donor 6-hydroxy-
methyl benzo(a)pyrene was carcinogenic
but had a low Iball index. Compounds
showing only weak acceptor or no complex
forming properties proved non-carcino-
genic. The results support the Huggins
and Yang hypothesis that either donor or
acceptor properties may be associated
with carcinogenicity and do not coincide
with the view that it is necessary to have
both properties within the same molecule.
It does, however, follow from our results
and the hypothesis of Huggins and Yang
that a compound with both donor and
acceptor properties would be carcinogenic
provided that the molecule fulfilled the
steric and other requirements for tumour
induction. The lack of carcinogenicity of
weak acceptors could be due to the target
site for the carcinogen having a binding
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group which is a strong acceptor but only
a weak donor. This hypothesis requires
testing with more compounds to eliminate
steric and other factors.
Comparison of 6-substituted benzo(a)-
pyrenes (present data) and the corre-
sponding 7-substitutedbenz(a)anthracenes
(data of Hueper and Conway (1944) and
Hartwell (1951)) shows that carcinogenic
activity runs parallel, for subcutaneous
injection, in the 2 series. The only
discrepancy is for the carbonitrile which
we found inactive in the 6-position of
benzo(a)pyrene but which has been re-
ported as a possible feeble carcinogen in
the 7-position of benz(a)anthracene. The
similarity in molecular geometry between
the 7-substituted benz(a)anthracenes and
the 6-substituted benzo(a)pyrenes makes
this parallelism in activity only to be
expected.
We are indebted to the late Professor
R. W. Scarff, C.B.E. for his advice and
help in the diagnosis of the tumours
found. We thank Mr F. Butcher for his
care of the animals. The expenses of one
of us (G.C.) were defrayed from a block
grant from the Cancer ResearchCampaign.
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